APO Research
Talk to an analyst

APO RESEARCH · REPORT

Teriflunomide API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Teriflunomide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025197 pages

Choose your research edition.

Industry ResearchTeriflunomide API Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Teriflunomide API Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Teriflunomide API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Teriflunomide API Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Teriflunomide API Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Teriflunomide API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Teriflunomide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Teriflunomide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Teriflunomide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Teriflunomide API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Teriflunomide API include Alembic Pharma, Aurobindo Pharma, Camus Pharma, Clearsynth Labs, Dr. Reddy's Laboratories, Enaltec Labs, Honour Lab, Laurel Pharma Labs and Megafine Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Teriflunomide API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Teriflunomide API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Teriflunomide API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Teriflunomide API market size, projected growth trends, production technologies, key applications, and end-use industries.

Teriflunomide API Segment by Company

Alembic Pharma

Aurobindo Pharma

Camus Pharma

Clearsynth Labs

Dr. Reddy's Laboratories

Enaltec Labs

Honour Lab

Laurel Pharma Labs

Megafine Pharma

MSN Laboratories

Natco Pharma

Par Chembio

Shilpa Pharma Lifesciences

Synzeal Research

Unichem Laboratories

VIVAN Life Sciences

Hangzhou Longshine Bio-Tech

Hefei Enrit Pharmaceutical

Jiangsu Yongan Pharmaceutical

Kivipharm

Nanjing Hengyang Pharmaceutical

Aurovitas Pharma Taizhou

Cinkate Pharmaceutical

Teriflunomide API Segment by Type

Purity≥98%

Purity≥99%

Teriflunomide API Segment by Application

Online Sales

Offline Sales

Teriflunomide API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriflunomide API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Teriflunomide API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriflunomide API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Teriflunomide API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Teriflunomide API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Teriflunomide API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Teriflunomide API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Teriflunomide API Industry Trends Table 2. Teriflunomide API Industry Drivers Table 3. Teriflunomide API Industry Opportunities and Challenges Table 4. Teriflunomide API Industry Restraints Table 5. Global Teriflunomide API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Teriflunomide API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Teriflunomide API Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Teriflunomide API Sales Market Share by Manufacturers Table 9. Global Teriflunomide API Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Teriflunomide API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Teriflunomide API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Teriflunomide API Manufacturers, Product Type & Application Table 13. Global Teriflunomide API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Teriflunomide API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity≥98% Table 17. Major Manufacturers of Purity≥99% Table 18. Global Teriflunomide API Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Teriflunomide API Sales by Type (2021-2026) & (Tons) Table 20. Global Teriflunomide API Sales by Type (2027-2032) & (Tons) Table 21. Global Teriflunomide API Sales Market Share by Type (2021-2026) Table 22. Global Teriflunomide API Sales Market Share by Type (2027-2032) Table 23. Global Teriflunomide API Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Teriflunomide API Revenue by Type (2021-2026) & (Tons) Table 25. Global Teriflunomide API Revenue by Type (2027-2032) & (Tons) Table 26. Global Teriflunomide API Revenue Market Share by Type (2021-2026) Table 27. Global Teriflunomide API Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Online Sales Table 29. Major Manufacturers of Offline Sales Table 30. Global Teriflunomide API Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 31. Global Teriflunomide API Sales by Application (2021-2026) & (Tons) Table 32. Global Teriflunomide API Sales by Application (2027-2032) & (Tons) Table 33. Global Teriflunomide API Sales Market Share by Application (2021-2026) Table 34. Global Teriflunomide API Sales Market Share by Application (2027-2032) Table 35. Global Teriflunomide API Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Teriflunomide API Revenue by Application (2021-2026) & (Tons) Table 37. Global Teriflunomide API Revenue by Application (2027-2032) & (Tons) Table 38. Global Teriflunomide API Revenue Market Share by Application (2021-2026) Table 39. Global Teriflunomide API Revenue Market Share by Application (2027-2032) Table 40. Global Teriflunomide API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 41. Global Teriflunomide API Sales by Region (2021-2026) & (Tons) Table 42. Global Teriflunomide API Sales Market Share by Region (2021-2026) Table 43. Global Teriflunomide API Sales Forecasted by Region (2027-2032) & (Tons) Table 44. Global Teriflunomide API Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Teriflunomide API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 46. North America Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 47. North America Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 48. Europe Teriflunomide API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 49. Europe Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 50. Europe Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 51. Asia Pacific Teriflunomide API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. Asia Pacific Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 53. Asia Pacific Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 54. South America, Middle East and Africa Teriflunomide API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. South America, Middle East and Africa Teriflunomide API Sales by Country (2021-2026) & (Tons) Table 56. South America, Middle East and Africa Teriflunomide API Sales by Country (2027-2032) & (Tons) Table 57. Global Teriflunomide API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Teriflunomide API Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Teriflunomide API Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Teriflunomide API Revenue Market Share by Region (2021-2026) Table 61. Global Teriflunomide API Revenue Market Share by Region (2027-2032) Table 62. Alembic Pharma Company Information Table 63. Alembic Pharma Business Overview Table 64. Alembic Pharma Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Alembic Pharma Teriflunomide API Product Portfolio Table 66. Alembic Pharma Recent Development Table 67. Aurobindo Pharma Company Information Table 68. Aurobindo Pharma Business Overview Table 69. Aurobindo Pharma Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Aurobindo Pharma Teriflunomide API Product Portfolio Table 71. Aurobindo Pharma Recent Development Table 72. Camus Pharma Company Information Table 73. Camus Pharma Business Overview Table 74. Camus Pharma Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Camus Pharma Teriflunomide API Product Portfolio Table 76. Camus Pharma Recent Development Table 77. Clearsynth Labs Company Information Table 78. Clearsynth Labs Business Overview Table 79. Clearsynth Labs Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Clearsynth Labs Teriflunomide API Product Portfolio Table 81. Clearsynth Labs Recent Development Table 82. Dr. Reddy's Laboratories Company Information Table 83. Dr. Reddy's Laboratories Business Overview Table 84. Dr. Reddy's Laboratories Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Dr. Reddy's Laboratories Teriflunomide API Product Portfolio Table 86. Dr. Reddy's Laboratories Recent Development Table 87. Enaltec Labs Company Information Table 88. Enaltec Labs Business Overview Table 89. Enaltec Labs Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Enaltec Labs Teriflunomide API Product Portfolio Table 91. Enaltec Labs Recent Development Table 92. Honour Lab Company Information Table 93. Honour Lab Business Overview Table 94. Honour Lab Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Honour Lab Teriflunomide API Product Portfolio Table 96. Honour Lab Recent Development Table 97. Laurel Pharma Labs Company Information Table 98. Laurel Pharma Labs Business Overview Table 99. Laurel Pharma Labs Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Laurel Pharma Labs Teriflunomide API Product Portfolio Table 101. Laurel Pharma Labs Recent Development Table 102. Megafine Pharma Company Information Table 103. Megafine Pharma Business Overview Table 104. Megafine Pharma Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Megafine Pharma Teriflunomide API Product Portfolio Table 106. Megafine Pharma Recent Development Table 107. MSN Laboratories Company Information Table 108. MSN Laboratories Business Overview Table 109. MSN Laboratories Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. MSN Laboratories Teriflunomide API Product Portfolio Table 111. MSN Laboratories Recent Development Table 112. Natco Pharma Company Information Table 113. Natco Pharma Business Overview Table 114. Natco Pharma Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Natco Pharma Teriflunomide API Product Portfolio Table 116. Natco Pharma Recent Development Table 117. Par Chembio Company Information Table 118. Par Chembio Business Overview Table 119. Par Chembio Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Par Chembio Teriflunomide API Product Portfolio Table 121. Par Chembio Recent Development Table 122. Shilpa Pharma Lifesciences Company Information Table 123. Shilpa Pharma Lifesciences Business Overview Table 124. Shilpa Pharma Lifesciences Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Shilpa Pharma Lifesciences Teriflunomide API Product Portfolio Table 126. Shilpa Pharma Lifesciences Recent Development Table 127. Synzeal Research Company Information Table 128. Synzeal Research Business Overview Table 129. Synzeal Research Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Synzeal Research Teriflunomide API Product Portfolio Table 131. Synzeal Research Recent Development Table 132. Unichem Laboratories Company Information Table 133. Unichem Laboratories Business Overview Table 134. Unichem Laboratories Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Unichem Laboratories Teriflunomide API Product Portfolio Table 136. Unichem Laboratories Recent Development Table 137. VIVAN Life Sciences Company Information Table 138. VIVAN Life Sciences Business Overview Table 139. VIVAN Life Sciences Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. VIVAN Life Sciences Teriflunomide API Product Portfolio Table 141. VIVAN Life Sciences Recent Development Table 142. Hangzhou Longshine Bio-Tech Company Information Table 143. Hangzhou Longshine Bio-Tech Business Overview Table 144. Hangzhou Longshine Bio-Tech Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Hangzhou Longshine Bio-Tech Teriflunomide API Product Portfolio Table 146. Hangzhou Longshine Bio-Tech Recent Development Table 147. Hefei Enrit Pharmaceutical Company Information Table 148. Hefei Enrit Pharmaceutical Business Overview Table 149. Hefei Enrit Pharmaceutical Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Hefei Enrit Pharmaceutical Teriflunomide API Product Portfolio Table 151. Hefei Enrit Pharmaceutical Recent Development Table 152. Jiangsu Yongan Pharmaceutical Company Information Table 153. Jiangsu Yongan Pharmaceutical Business Overview Table 154. Jiangsu Yongan Pharmaceutical Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Jiangsu Yongan Pharmaceutical Teriflunomide API Product Portfolio Table 156. Jiangsu Yongan Pharmaceutical Recent Development Table 157. Kivipharm Company Information Table 158. Kivipharm Business Overview Table 159. Kivipharm Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Kivipharm Teriflunomide API Product Portfolio Table 161. Kivipharm Recent Development Table 162. Nanjing Hengyang Pharmaceutical Company Information Table 163. Nanjing Hengyang Pharmaceutical Business Overview Table 164. Nanjing Hengyang Pharmaceutical Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Nanjing Hengyang Pharmaceutical Teriflunomide API Product Portfolio Table 166. Nanjing Hengyang Pharmaceutical Recent Development Table 167. Aurovitas Pharma Taizhou Company Information Table 168. Aurovitas Pharma Taizhou Business Overview Table 169. Aurovitas Pharma Taizhou Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 170. Aurovitas Pharma Taizhou Teriflunomide API Product Portfolio Table 171. Aurovitas Pharma Taizhou Recent Development Table 172. Cinkate Pharmaceutical Company Information Table 173. Cinkate Pharmaceutical Business Overview Table 174. Cinkate Pharmaceutical Teriflunomide API Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 175. Cinkate Pharmaceutical Teriflunomide API Product Portfolio Table 176. Cinkate Pharmaceutical Recent Development Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Teriflunomide API Distributors List Table 180. Teriflunomide API Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Teriflunomide API Product Image Figure 2. Global Teriflunomide API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Teriflunomide API Market Size (2021-2032) & (US$ Million) Figure 4. Global Teriflunomide API Sales (2021-2032) & (Tons) Figure 5. Global Teriflunomide API Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Teriflunomide API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity≥98% Image Figure 9. Purity≥99% Image Figure 10. Global Teriflunomide API Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Teriflunomide API Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Teriflunomide API Sales Market Share by Type (2021-2032) Figure 13. Global Teriflunomide API Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Teriflunomide API Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Teriflunomide API Revenue Market Share by Type (2021-2032) Figure 16. Online Sales Image Figure 17. Offline Sales Image Figure 18. Global Teriflunomide API Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 19. Global Teriflunomide API Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Teriflunomide API Sales Market Share by Application (2021-2032) Figure 21. Global Teriflunomide API Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Teriflunomide API Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Teriflunomide API Revenue Market Share by Application (2021-2032) Figure 24. North America Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 25. North America Teriflunomide API Sales Market Share by Country (2021-2032) Figure 26. U.S. Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 27. Canada Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Mexico Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Europe Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Teriflunomide API Sales Market Share by Country (2021-2032) Figure 31. Germany Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 32. France Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 33. U.K. Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Italy Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Netherlands Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Asia Pacific Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Teriflunomide API Sales Market Share by Country (2021-2032) Figure 38. China Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Japan Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 40. South Korea Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Southeast Asia Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 42. India Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Australia Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 44. South America, Middle East and Africa Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Teriflunomide API Sales Market Share by Country (2021-2032) Figure 46. Brazil Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South Africa Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Saudi Arabia Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Turkey Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Argentina Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 51. UAE Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Egypt Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Chile Teriflunomide API Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Global Teriflunomide API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Teriflunomide API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Teriflunomide API Revenue (2021-2032) & (US$ Million) Figure 57. North America Teriflunomide API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Teriflunomide API Revenue (2021-2032) & (US$ Million) Figure 59. Europe Teriflunomide API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Teriflunomide API Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Teriflunomide API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Teriflunomide API Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Teriflunomide API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Teriflunomide API Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Teriflunomide API Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥98%
  • Purity≥99%
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Alembic Pharma
  • Aurobindo Pharma
  • Camus Pharma
  • Clearsynth Labs
  • Dr. Reddy's Laboratories
  • Enaltec Labs
  • Honour Lab
  • Laurel Pharma Labs
  • Megafine Pharma
  • MSN Laboratories
  • Natco Pharma
  • Par Chembio
  • Shilpa Pharma Lifesciences
  • Synzeal Research
  • Unichem Laboratories
  • VIVAN Life Sciences
  • Hangzhou Longshine Bio-Tech
  • Hefei Enrit Pharmaceutical
  • Jiangsu Yongan Pharmaceutical
  • Kivipharm
  • Nanjing Hengyang Pharmaceutical
  • Aurovitas Pharma Taizhou
  • Cinkate Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Teriflunomide API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Teriflunomide API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Teriflunomide API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Teriflunomide API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Teriflunomide API Market Dynamics
  1. 2.1 Teriflunomide API Industry Trends
  2. 2.2 Teriflunomide API Industry Drivers
  3. 2.3 Teriflunomide API Industry Opportunities and Challenges
  4. 2.4 Teriflunomide API Industry Restraints
3 Teriflunomide API Market by Manufacturers
  1. 3.1 Global Teriflunomide API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Teriflunomide API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Teriflunomide API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Teriflunomide API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Teriflunomide API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Teriflunomide API Manufacturers, Product Type & Application
  7. 3.7 Global Teriflunomide API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Teriflunomide API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Teriflunomide API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Teriflunomide API Tier 1, Tier 2, and Tier 3
4 Teriflunomide API Market by Type
  1. 4.1 Teriflunomide API Type Introduction
  2. 4.1.1 Purity≥98%
  3. 4.1.2 Purity≥99%
  4. 4.2 Global Teriflunomide API Sales by Type
  5. 4.2.1 Global Teriflunomide API Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Teriflunomide API Sales by Type (2021-2032)
  7. 4.2.3 Global Teriflunomide API Sales Market Share by Type (2021-2032)
  8. 4.3 Global Teriflunomide API Revenue by Type
  9. 4.3.1 Global Teriflunomide API Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Teriflunomide API Revenue by Type (2021-2032)
  11. 4.3.3 Global Teriflunomide API Revenue Market Share by Type (2021-2032)
5 Teriflunomide API Market by Application
  1. 5.1 Teriflunomide API Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Teriflunomide API Sales by Application
  5. 5.2.1 Global Teriflunomide API Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Teriflunomide API Sales by Application (2021-2032)
  7. 5.2.3 Global Teriflunomide API Sales Market Share by Application (2021-2032)
  8. 5.3 Global Teriflunomide API Revenue by Application
  9. 5.3.1 Global Teriflunomide API Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Teriflunomide API Revenue by Application (2021-2032)
  11. 5.3.3 Global Teriflunomide API Revenue Market Share by Application (2021-2032)
6 Global Teriflunomide API Sales by Region
  1. 6.1 Global Teriflunomide API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Teriflunomide API Sales by Region (2021-2032)
  3. 6.2.1 Global Teriflunomide API Sales by Region (2021-2026)
  4. 6.2.2 Global Teriflunomide API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Teriflunomide API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Teriflunomide API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Teriflunomide API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Teriflunomide API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Teriflunomide API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Teriflunomide API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Teriflunomide API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Teriflunomide API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Teriflunomide API Revenue by Region
  1. 7.1 Global Teriflunomide API Revenue by Region
  2. 7.1.1 Global Teriflunomide API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Teriflunomide API Revenue by Region (2021-2026)
  4. 7.1.3 Global Teriflunomide API Revenue by Region (2027-2032)
  5. 7.1.4 Global Teriflunomide API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Teriflunomide API Revenue (2021-2032)
  8. 7.2.2 North America Teriflunomide API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Teriflunomide API Revenue (2021-2032)
  11. 7.3.2 Europe Teriflunomide API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Teriflunomide API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Teriflunomide API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Teriflunomide API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Teriflunomide API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic Pharma
  2. 8.1.1 Alembic Pharma Company Information
  3. 8.1.2 Alembic Pharma Business Overview
  4. 8.1.3 Alembic Pharma Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Pharma Teriflunomide API Product Portfolio
  6. 8.1.5 Alembic Pharma Recent Developments
  7. 8.2 Aurobindo Pharma
  8. 8.2.1 Aurobindo Pharma Company Information
  9. 8.2.2 Aurobindo Pharma Business Overview
  10. 8.2.3 Aurobindo Pharma Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aurobindo Pharma Teriflunomide API Product Portfolio
  12. 8.2.5 Aurobindo Pharma Recent Developments
  13. 8.3 Camus Pharma
  14. 8.3.1 Camus Pharma Company Information
  15. 8.3.2 Camus Pharma Business Overview
  16. 8.3.3 Camus Pharma Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Camus Pharma Teriflunomide API Product Portfolio
  18. 8.3.5 Camus Pharma Recent Developments
  19. 8.4 Clearsynth Labs
  20. 8.4.1 Clearsynth Labs Company Information
  21. 8.4.2 Clearsynth Labs Business Overview
  22. 8.4.3 Clearsynth Labs Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Clearsynth Labs Teriflunomide API Product Portfolio
  24. 8.4.5 Clearsynth Labs Recent Developments
  25. 8.5 Dr. Reddy's Laboratories
  26. 8.5.1 Dr. Reddy's Laboratories Company Information
  27. 8.5.2 Dr. Reddy's Laboratories Business Overview
  28. 8.5.3 Dr. Reddy's Laboratories Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy's Laboratories Teriflunomide API Product Portfolio
  30. 8.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 8.6 Enaltec Labs
  32. 8.6.1 Enaltec Labs Company Information
  33. 8.6.2 Enaltec Labs Business Overview
  34. 8.6.3 Enaltec Labs Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Enaltec Labs Teriflunomide API Product Portfolio
  36. 8.6.5 Enaltec Labs Recent Developments
  37. 8.7 Honour Lab
  38. 8.7.1 Honour Lab Company Information
  39. 8.7.2 Honour Lab Business Overview
  40. 8.7.3 Honour Lab Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Honour Lab Teriflunomide API Product Portfolio
  42. 8.7.5 Honour Lab Recent Developments
  43. 8.8 Laurel Pharma Labs
  44. 8.8.1 Laurel Pharma Labs Company Information
  45. 8.8.2 Laurel Pharma Labs Business Overview
  46. 8.8.3 Laurel Pharma Labs Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Laurel Pharma Labs Teriflunomide API Product Portfolio
  48. 8.8.5 Laurel Pharma Labs Recent Developments
  49. 8.9 Megafine Pharma
  50. 8.9.1 Megafine Pharma Company Information
  51. 8.9.2 Megafine Pharma Business Overview
  52. 8.9.3 Megafine Pharma Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Megafine Pharma Teriflunomide API Product Portfolio
  54. 8.9.5 Megafine Pharma Recent Developments
  55. 8.10 MSN Laboratories
  56. 8.10.1 MSN Laboratories Company Information
  57. 8.10.2 MSN Laboratories Business Overview
  58. 8.10.3 MSN Laboratories Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MSN Laboratories Teriflunomide API Product Portfolio
  60. 8.10.5 MSN Laboratories Recent Developments
  61. 8.11 Natco Pharma
  62. 8.11.1 Natco Pharma Company Information
  63. 8.11.2 Natco Pharma Business Overview
  64. 8.11.3 Natco Pharma Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Natco Pharma Teriflunomide API Product Portfolio
  66. 8.11.5 Natco Pharma Recent Developments
  67. 8.12 Par Chembio
  68. 8.12.1 Par Chembio Company Information
  69. 8.12.2 Par Chembio Business Overview
  70. 8.12.3 Par Chembio Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Par Chembio Teriflunomide API Product Portfolio
  72. 8.12.5 Par Chembio Recent Developments
  73. 8.13 Shilpa Pharma Lifesciences
  74. 8.13.1 Shilpa Pharma Lifesciences Company Information
  75. 8.13.2 Shilpa Pharma Lifesciences Business Overview
  76. 8.13.3 Shilpa Pharma Lifesciences Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shilpa Pharma Lifesciences Teriflunomide API Product Portfolio
  78. 8.13.5 Shilpa Pharma Lifesciences Recent Developments
  79. 8.14 Synzeal Research
  80. 8.14.1 Synzeal Research Company Information
  81. 8.14.2 Synzeal Research Business Overview
  82. 8.14.3 Synzeal Research Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Synzeal Research Teriflunomide API Product Portfolio
  84. 8.14.5 Synzeal Research Recent Developments
  85. 8.15 Unichem Laboratories
  86. 8.15.1 Unichem Laboratories Company Information
  87. 8.15.2 Unichem Laboratories Business Overview
  88. 8.15.3 Unichem Laboratories Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Unichem Laboratories Teriflunomide API Product Portfolio
  90. 8.15.5 Unichem Laboratories Recent Developments
  91. 8.16 VIVAN Life Sciences
  92. 8.16.1 VIVAN Life Sciences Company Information
  93. 8.16.2 VIVAN Life Sciences Business Overview
  94. 8.16.3 VIVAN Life Sciences Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 VIVAN Life Sciences Teriflunomide API Product Portfolio
  96. 8.16.5 VIVAN Life Sciences Recent Developments
  97. 8.17 Hangzhou Longshine Bio-Tech
  98. 8.17.1 Hangzhou Longshine Bio-Tech Company Information
  99. 8.17.2 Hangzhou Longshine Bio-Tech Business Overview
  100. 8.17.3 Hangzhou Longshine Bio-Tech Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hangzhou Longshine Bio-Tech Teriflunomide API Product Portfolio
  102. 8.17.5 Hangzhou Longshine Bio-Tech Recent Developments
  103. 8.18 Hefei Enrit Pharmaceutical
  104. 8.18.1 Hefei Enrit Pharmaceutical Company Information
  105. 8.18.2 Hefei Enrit Pharmaceutical Business Overview
  106. 8.18.3 Hefei Enrit Pharmaceutical Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Hefei Enrit Pharmaceutical Teriflunomide API Product Portfolio
  108. 8.18.5 Hefei Enrit Pharmaceutical Recent Developments
  109. 8.19 Jiangsu Yongan Pharmaceutical
  110. 8.19.1 Jiangsu Yongan Pharmaceutical Company Information
  111. 8.19.2 Jiangsu Yongan Pharmaceutical Business Overview
  112. 8.19.3 Jiangsu Yongan Pharmaceutical Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Jiangsu Yongan Pharmaceutical Teriflunomide API Product Portfolio
  114. 8.19.5 Jiangsu Yongan Pharmaceutical Recent Developments
  115. 8.20 Kivipharm
  116. 8.20.1 Kivipharm Company Information
  117. 8.20.2 Kivipharm Business Overview
  118. 8.20.3 Kivipharm Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Kivipharm Teriflunomide API Product Portfolio
  120. 8.20.5 Kivipharm Recent Developments
  121. 8.21 Nanjing Hengyang Pharmaceutical
  122. 8.21.1 Nanjing Hengyang Pharmaceutical Company Information
  123. 8.21.2 Nanjing Hengyang Pharmaceutical Business Overview
  124. 8.21.3 Nanjing Hengyang Pharmaceutical Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Nanjing Hengyang Pharmaceutical Teriflunomide API Product Portfolio
  126. 8.21.5 Nanjing Hengyang Pharmaceutical Recent Developments
  127. 8.22 Aurovitas Pharma Taizhou
  128. 8.22.1 Aurovitas Pharma Taizhou Company Information
  129. 8.22.2 Aurovitas Pharma Taizhou Business Overview
  130. 8.22.3 Aurovitas Pharma Taizhou Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Aurovitas Pharma Taizhou Teriflunomide API Product Portfolio
  132. 8.22.5 Aurovitas Pharma Taizhou Recent Developments
  133. 8.23 Cinkate Pharmaceutical
  134. 8.23.1 Cinkate Pharmaceutical Company Information
  135. 8.23.2 Cinkate Pharmaceutical Business Overview
  136. 8.23.3 Cinkate Pharmaceutical Teriflunomide API Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Cinkate Pharmaceutical Teriflunomide API Product Portfolio
  138. 8.23.5 Cinkate Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Teriflunomide API Value Chain Analysis
  2. 9.1.1 Teriflunomide API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Teriflunomide API Production Mode & Process
  6. 9.2 Teriflunomide API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Teriflunomide API Distributors
  9. 9.2.3 Teriflunomide API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst